{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:03Z","timestamp":1793409663282,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00516","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T04:54:35Z","timestamp":1576040075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Hematopoietic Cell Transplantation for MHC Class II Deficiency"],"prefix":"10.3389","volume":"7","author":[{"given":"Su Han","family":"Lum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"B1","first-page":"87","article-title":"Combined immunodeficiency with defective expression of HLA: modulation of an abnormal HLA synthesis and functional studies","volume":"19","author":"Lisowska-Grospierre","year":"1983","journal-title":"Birth Defects Orig Artic Ser"},{"key":"B2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev.immunol.14.1.301","article-title":"Regulation of MHC class II genes: lessons from a disease","volume":"14","author":"Mach","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/adc.83.4.356","article-title":"Clinical course of patients with major histocompatibility complex class II deficiency","volume":"83","author":"Saleem","year":"2000","journal-title":"Arch Dis Child"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s10875-013-9952-8","article-title":"Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study","volume":"33","author":"Rozmus","year":"2013","journal-title":"J Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10875-012-9831-8","article-title":"Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile","volume":"33","author":"Al-Herz","year":"2013","journal-title":"J Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nri1708","article-title":"Regulation of MHC class II gene expression by the class II transactivator","volume":"5","author":"Reith","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","article-title":"MHC class I and II deficiencies","volume":"134","author":"Hanna","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jaci.2012.10.040","article-title":"Thymic function in MHC class II-deficient patients","volume":"131","author":"Lev","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12026-018-9019-2","article-title":"MHC II deficient infant identified by newborn screening program for SCID","volume":"66","author":"Marcus","year":"2018","journal-title":"Immunol Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fimmu.2018.00188","article-title":"Clinical, immunological, and molecular findings in five patients with major histocompatibility complex class II deficiency from India","volume":"9","author":"Aluri","year":"2018","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0022-3476(05)80388-9","article-title":"Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome","volume":"123","author":"Klein","year":"1993","journal-title":"J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1182\/blood-2011-05-352716","article-title":"Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients","volume":"118","author":"Ouederni","year":"2011","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/blood.V85.2.580.580","article-title":"Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients","volume":"85","author":"Klein","year":"1995","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/bmt.2012.140","article-title":"Alternative donor SCT for the treatment of MHC class II deficiency","volume":"48","author":"Small","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor alphabeta(+) and CD19(+) cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bbmt.2010.01.002","article-title":"Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency","volume":"16","author":"Al-Mousa","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0198-8859(83)90051-4","article-title":"Strong HLA-DR expression in T cell cultures after activation is necessary for IL-2-dependent proliferation","volume":"8","author":"Effros","year":"1983","journal-title":"Hum Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbmt.2017.11.009","article-title":"Treosulfan and fludarabine conditioning for hematopoietic stem cell transplantation in children with primary immunodeficiency: UK experience","volume":"24","author":"Slatter","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"E80","DOI":"10.1111\/j.1399-3046.2010.01292.x","article-title":"MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature","volume":"15","author":"Siepermann","year":"2011","journal-title":"Pediatr Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1365-2141.2006.06213.x","article-title":"Human leucocyte antigen-identical hematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections","volume":"134","author":"Renella","year":"2006","journal-title":"Br J Haematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1182\/blood.V94.1.348.413k05_348_358","article-title":"Incomplete T-cell immune reconstitution in two major histocompatibility complex class II-deficiency\/bare lymphocyte syndrome patients after HLA-identical sibling bone marrow transplantation","volume":"94","author":"Godthelp","year":"1999","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1701915","article-title":"Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency","volume":"24","author":"Bonduel","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1182\/blood.V83.4.1149.1149","article-title":"Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency","volume":"83","author":"Fischer","year":"1994","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S0198-8859(00)00156-7","article-title":"T cell immune reconstitution after allogeneic bone marrow transplantation in bare lymphocyte syndrome","volume":"61","author":"Godthelp","year":"2000","journal-title":"Hum Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.jaci.2017.10.051","article-title":"Umbilical cord blood transplantation without in vivo T-cell depletion for children with MHC class II deficiency","volume":"141","author":"Elfeky","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1152\/nips.01462.2003","article-title":"Cellular and gene therapy for major histocompatibility complex class II deficiency","volume":"19","author":"Matheux","year":"2004","journal-title":"News Physiol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molmed.2016.02.002","article-title":"Treating immunodeficiency through HSC gene therapy","volume":"22","author":"Booth","year":"2016","journal-title":"Trends Mol Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00516\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T04:54:37Z","timestamp":1576040077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00516\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":28,"alternative-id":["10.3389\/fped.2019.00516"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00516","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"article-number":"516"}}